loadpatents
name:-0.44598293304443
name:-0.41654515266418
name:-0.0089738368988037
ROECKER; Anthony J. Patent Filings

ROECKER; Anthony J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for ROECKER; Anthony J..The latest application filed is for "hydroxypyrrolidine-substituted arylsulfonamide compounds with selective activity in voltage-gated sodium channels".

Company Profile
11.32.39
  • ROECKER; Anthony J. - West Point PA US
  • Roecker; Anthony J. - Harleysville PA
  • Roecker; Anthony J. - North Wales PA US
  • - North Wales PA US
  • Roecker; Anthony J. - Blue Bell PA
  • Roecker; Anthony J. - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Hydroxypyrrolidine-substituted Arylsulfonamide Compounds With Selective Activity In Voltage-gated Sodium Channels
App 20220305035 - Roecker; Anthony J. ;   et al.
2022-09-29
Spiropiperidine Allosteric Modulators Of Nicotinic Acetylcholine Receptors
App 20220119351 - Bell; Ian M. ;   et al.
2022-04-21
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
Grant 10,968,210 - Greshock , et al. April 6, 2
2021-04-06
Diamino-alkylamino-linked Arylsulfonamide Compounds With Selective Activity In Voltage-gated Sodium Channels
App 20200131167 - Greshock; Thomas J. ;   et al.
2020-04-30
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
Grant 10,519,147 - Greshock , et al. Dec
2019-12-31
N1-phenylpropane-1,2-diamine compounds with selective activity in voltage-gated sodium channels
Grant 10,442,778 - Roecker , et al. Oc
2019-10-15
HYDROXYALKYLAMINE- and HYDROXYCYCLOALKYLAMINE-SUBSTITUTED DIAMINE-ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-G
App 20190233406 - Greshock; Thomas J. ;   et al.
2019-08-01
N1-phenylpropane-1,2-diamine Compounds With Selective Activity In Voltage-gated Sodium Channels
App 20190092738 - Roecker; Anthony J. ;   et al.
2019-03-28
Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels
Grant 10,221,167 - Greshock , et al.
2019-03-05
DIAMINO-ALKYLAMINO-Linked ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS
App 20180362518 - Greshock; Thomas J. ;   et al.
2018-12-20
Bridged diazepane orexin receptor antagonists
Grant 9,994,570 - Kuduk , et al. June 12, 2
2018-06-12
Bridged Diazepane Orexin Receptor Antagonists
App 20170320876 - KUDUK; SCOTT D. ;   et al.
2017-11-09
Diazepane orexin receptor antagonists
Grant 9,732,077 - Kuduk , et al. August 15, 2
2017-08-15
HYDROXYALKYLAMINE- and HYDROXYCYCLOALKYLAMINE-SUBSTITUTED DIAMINE-ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS
App 20170174674 - Greshock; Thomas J. ;   et al.
2017-06-22
Bicycloamine-substituted-N-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels
Grant 9,586,968 - Layton , et al. March 7, 2
2017-03-07
Bicycloamine-substituted-n-benzenesulfonamide Compounds With Selective Activity In Voltage-gated Sodium Channels
App 20170002008 - Layton; Mark E. ;   et al.
2017-01-05
Diazepane Orexin Receptor Antagonists
App 20160318923 - KUDUK; SCOTT D. ;   et al.
2016-11-03
Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
Grant 9,273,040 - Layton , et al. March 1, 2
2016-03-01
Isoxazolopyridine orexin receptor antagonists
Grant 9,242,995 - Li , et al. January 26, 2
2016-01-26
Isoxazolopyridine Orexin Receptor Antagonists
App 20150038502 - Li; Dansu ;   et al.
2015-02-05
Benzoxazolinone Compounds With Selective Activity In Voltage-gated Sodium Channels
App 20140303143 - Layton; Mark E. ;   et al.
2014-10-09
2,5-disubstituted piperidine orexin receptor antagonists
Grant 8,710,076 - Breslin , et al. April 29, 2
2014-04-29
Pyridazine carboxamide orexin receptor antagonists
Grant 8,703,770 - Coleman , et al. April 22, 2
2014-04-22
Bridged diazepan orexin receptor antagonists
Grant 08618102 -
2013-12-31
Bridged diazepan orexin receptor antagonists
Grant 8,618,102 - Coleman , et al. December 31, 2
2013-12-31
Isonicotinamide orexin receptor antagonists
Grant 8,592,457 - Bergman , et al. November 26, 2
2013-11-26
Tricyclic Mglur5 Receptor Modulators
App 20130210804 - Anthony; Neville J. ;   et al.
2013-08-15
Bipyridine carboxamide orexin receptor antagonists
Grant 8,410,142 - Coleman , et al. April 2, 2
2013-04-02
2,5-disubstituted phenyl carboxamide orexin receptor antagonists
Grant 8,399,494 - Bergman , et al. March 19, 2
2013-03-19
Substituted diazepan orexin receptor antagonists
Grant 8,362,009 - Bergman , et al. January 29, 2
2013-01-29
Tripyridyl carboxamide orexin receptor antagonists
Grant 8,349,872 - Coleman , et al. January 8, 2
2013-01-08
Tertiary Amide Orexin Receptor Antagonists
App 20120196901 - Coleman; Paul J. ;   et al.
2012-08-02
Tetrahydronapthyridine Orexin Receptor Antagonists
App 20120101106 - Mercer; Swati P. ;   et al.
2012-04-26
Pyrazine Carboxamide Orexin Receptor Antagonists
App 20120065205 - Mercer; Swati P. ;   et al.
2012-03-15
Pyridazine Carboxamide Orexin Receptor Antagonists
App 20120046289 - Coleman; Paul J. ;   et al.
2012-02-23
2-alkyl Piperidine Mglur5 Receptor Modulators
App 20120040998 - Mercer; Swati P. ;   et al.
2012-02-16
Pyridine Carboxamide orexin Receptor Antagonists
App 20110301140 - Bergman; Jeffrey M. ;   et al.
2011-12-08
Cyclopropyl pyrrolidine orexin receptor antagonists
Grant 8,030,495 - Coleman , et al. October 4, 2
2011-10-04
2,5-Disubstituted Phenyl Carboxamide Orexin Receptor Antagonists
App 20110207747 - Bergman; Jeffrey M. ;   et al.
2011-08-25
Pyridine carboxamide orexin receptor antagonists
Grant 8,003,797 - Bergman , et al. August 23, 2
2011-08-23
2,5-Disubstituted Piperidine Orexin Rceptor Antagonists
App 20110201632 - Breslin; Michael J. ;   et al.
2011-08-18
Isonicotinamide Orexin Receptor Antagonists
App 20110201591 - Bergman; Jeffrey M. ;   et al.
2011-08-18
Substituted Diazepan Orexin Receptor Antagonists
App 20110195957 - Bergman; Jeffrey M. ;   et al.
2011-08-11
Substituted Diazepan Orexin Receptor Antagonists
App 20100256121 - Bergman; Jeffrey M. ;   et al.
2010-10-07
Pyridine Carboxamide Orexin Receptor Antagonists
App 20100197652 - Bergman; Jeffrey M. ;   et al.
2010-08-05
Cyclopropyl Pyrrolidine Orexin Receptor Antagonists
App 20100152191 - Coleman; Paul J. ;   et al.
2010-06-17
Bipyridine Carboxamide Orexin Receptor Antagonists
App 20100063056 - Coleman; Paul J. ;   et al.
2010-03-11
Bridged diazepan orexin receptor antagonists
App 20090239843 - Coleman; Paul J. ;   et al.
2009-09-24
Proline bis-amide orexin receptor antagonists
App 20090118200 - Bergman; Jeffrey M. ;   et al.
2009-05-07
Indole Orexin Receptor Antagonists
App 20090088452 - Coleman; Paul J. ;   et al.
2009-04-02
Substituted diazepan orexin receptor antagonists
App 20080132490 - Bergman; Jeffrey M. ;   et al.
2008-06-05
Mitotic Kinesin Inhibitors
App 20080045492 - Coleman; Paul J. ;   et al.
2008-02-21
Non-steroidal farnesoid x receptor modulators
App 20060223879 - Downes; Michael R. ;   et al.
2006-10-05
Non-steroidal farnesoid X receptor modulators and methods for the use thereof
App 20050143449 - Downes, Michael R. ;   et al.
2005-06-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed